Replies to post #184290 on NorthWest Biotherapeutics Inc (NWBO)

[Ultraz2]

Hence, why the FDA would be fools not to approve DC therapy if appropriate for a subgroup if patients...and for further research in combo trials. I can’t see them throwing away 20 years of research if effective for some at this point. They won’t do it...unless influenced by special interests.